RWEALLIANCE.ORG: Keyword Density Checker

Total words: 1210 | 2-word phrases: 294 | 3-word phrases: 361 | 4-word phrases: 397

PAGE INFO

Title	Try to keep the title under 60 characters (12 characters) RWE Alliance
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	the rwe alliance	7	1.94%
2	fda issued draft	5	1.39%
3	issued draft guidance	5	1.39%
4	policy document •	5	1.39%
5	document • comments	5	1.39%
6	this draft guidance	5	1.39%
7	drug and biological	5	1.39%
8	for drug and	5	1.39%
9	draft guidance titled	5	1.39%
10	• comments fda	4	1.11%
11	and biological product	3	0.83%
12	commented on the	3	0.83%
13	on the draft	3	0.83%
14	the draft guidance	3	0.83%
15	draft guidance in	3	0.83%
16	electronic health records	3	0.83%
17	and fda issued	3	0.83%
18	fda issued final	3	0.83%
19	fda guidance on	3	0.83%
20	regulatory decisionmaking for	3	0.83%
21	2023 fda final	3	0.83%
22	see the rwe	3	0.83%
23	externally controlled trials	3	0.83%
24	rwe alliance comments	3	0.83%
25	2021 fda issued	3	0.83%
26	fda final guidance	3	0.83%
27	decisionmaking for drug	3	0.83%
28	realworld data and	3	0.83%
29	more about the	3	0.83%
30	“considerations for the	2	0.55%

#	Keyword	Frequency	Density
1	policy document • comments	5	1.26%
2	for drug and biological	5	1.26%
3	issued draft guidance titled	5	1.26%
4	fda issued draft guidance	4	1.01%
5	regulatory decisionmaking for drug	3	0.76%
6	2021 fda issued draft	3	0.76%
7	and fda issued final	3	0.76%
8	document • comments fda	3	0.76%
9	see the rwe alliance	3	0.76%
10	decisionmaking for drug and	3	0.76%
11	drug and biological product	3	0.76%
12	the draft guidance in	3	0.76%
13	on the draft guidance	3	0.76%
14	commented on the draft	3	0.76%
15	2023 fda final guidance	3	0.76%
16	the rwe alliance commented	2	0.50%
17	rwe alliance comments policy	2	0.50%
18	draft guidance titled “realworld	2	0.50%
19	alliance commented on the	2	0.50%
20	the rwe alliance comments	2	0.50%
21	2022 and fda issued	2	0.50%
22	alliance comments policy document	2	0.50%
23	drug and biological products	2	0.50%
24	products” this draft guidance	2	0.50%
25	health records and medical	2	0.50%
26	in december 2023 learn	2	0.50%
27	guidance in december 2023	2	0.50%
28	final guidance in december	2	0.50%
29	support regulatory decisionmaking for	2	0.50%
30	guidance provides recommendations for	2	0.50%
31	provides recommendations for using	2	0.50%
32	draft guidance provided recommendations	2	0.50%
33	this draft guidance provided	2	0.50%
34	fda guidance on data	2	0.50%
35	• comments fda guidance	2	0.50%
36	comments fda guidance on	2	0.50%
37	electronic health records and	2	0.50%
38	rwe alliance commented on	2	0.50%
39	records and medical claims	2	0.50%
40	harnessing the power of	2	0.50%